{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:40:19Z","timestamp":1761946819491},"reference-count":280,"publisher":"Elsevier","isbn-type":[{"value":"9780128136898","type":"print"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/b978-0-12-813689-8.00014-8","type":"book-chapter","created":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T14:34:05Z","timestamp":1527258845000},"page":"517-565","source":"Crossref","is-referenced-by-count":5,"title":["Delivering miRNA modulators for cancer treatment"],"prefix":"10.1016","author":[{"given":"Marilene","family":"Estanqueiro","sequence":"first","affiliation":[]},{"given":"Helena","family":"Vasconcelos","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Manuel","family":"Sousa Lobo","sequence":"additional","affiliation":[]},{"given":"Helena","family":"Amaral","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2007.03.005","article-title":"RNAi therapeutics: principles, prospects and challenges","volume":"59","author":"Aagaard","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/B978-0-12-813689-8.00014-8_bib2","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1080\/15384047.2016.1235657","article-title":"MiR-339 and especially miR-766 reactivate the expression of tumor suppressor genes in colorectal cancer cell lines through DNA methyltransferase 3B gene inhibition","volume":"17","author":"Afgar","year":"2016","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/mt.2010.254","article-title":"Microvesicle-mediated RNA molecule delivery system using monocytes\/macrophages","volume":"19","author":"Akao","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3844\/ajptsp.2008.219.224","article-title":"Tamoxifen drug loading solid lipid nanoparticles prepared by hot high pressure homogenization techniques","volume":"3","author":"ALHaj","year":"2008","journal-title":"Am. J. Pharmacol. Toxicol."},{"issue":"5","key":"10.1016\/B978-0-12-813689-8.00014-8_bib5","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.3892\/mmr.2016.5753","article-title":"Matrine induces cell cycle arrest and apoptosis with recovery of the expression of miR-126 in the A549 nonsmall cell lung cancer cell line","volume":"14","author":"An","year":"2016","journal-title":"Mol. Med. Rep"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib6","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1021\/acs.molpharmaceut.6b00388","article-title":"Tailored nanoparticle codelivery of antimiR-21 and antimiR-10b augments glioblastoma cell kill by temozolomide: toward a \u201cpersonalized\u201d anti-microRNA therapy","volume":"13","author":"Ananta","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/jgm.2744","article-title":"Polycation liposomes as a vector for potential intracellular delivery of microRNA","volume":"15","author":"Ando","year":"2013","journal-title":"J. Gene Med."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib8","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/diagnostics3010170","article-title":"Development of microRNA therapeutics for hepatocellular carcinoma","volume":"3","author":"Aravalli","year":"2013","journal-title":"Diagnostics"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib9","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1517\/17425247.2015.996545","article-title":"Liposomal delivery of nucleic acid-based anticancer therapeutics: BP-100-1.01","volume":"12","author":"Ashizawa","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib10","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.febslet.2010.12.027","article-title":"Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line","volume":"585","author":"Bai","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib11","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1155\/2011\/326497","article-title":"Liposomes for use in gene delivery","volume":"2011","author":"Balazs","year":"2011","journal-title":"J. Drug Deliv."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae\u2014The first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Controlled Release"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"issue":"12","key":"10.1016\/B978-0-12-813689-8.00014-8_bib15","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1080\/17425247.2016.1201059","article-title":"Application of lipid nanoparticles to ocular drug delivery","volume":"13","author":"Battaglia","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib16","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1002\/smll.201500540","article-title":"Combined delivery of temozolomide and anti-miR221 PNA using mesoporous silica nanoparticles induces apoptosis in resistant glioma cells","volume":"11","author":"Bertucci","year":"2015","journal-title":"Small"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib17","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/j.1600-0854.2011.01225.x","article-title":"Exosome secretion: molecular mechanisms and roles in immune responses","volume":"12","author":"Bobrie","year":"2011","journal-title":"Traffic"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib18","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/mt.2014.98","article-title":"miR-148a-and miR-216a-regulated oncolytic adenoviruses targeting pancreatic tumors attenuate tissue damage without perturbation of miRNA activity","volume":"22","author":"Bofill-De Ros","year":"2014","journal-title":"Mole. Ther."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib19","doi-asserted-by":"crossref","first-page":"120066","DOI":"10.1098\/rsob.120066","article-title":"Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?","volume":"2","author":"Borst","year":"2012","journal-title":"Open Biol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib20","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1073\/pnas.92.16.7297","article-title":"A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine","volume":"92","author":"Boussif","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib21","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s13277-015-3950-9","article-title":"miR-15a enhances the anticancer effects of cisplatin in the resistant non-small cell lung cancer cells","volume":"37","author":"Bozok Cetintas","year":"2016","journal-title":"Tumour Biol."},{"issue":"43","key":"10.1016\/B978-0-12-813689-8.00014-8_bib22","doi-asserted-by":"crossref","first-page":"70388","DOI":"10.18632\/oncotarget.11865","article-title":"Novel tumor suppressor microRNA at frequently deleted chromosomal region 8p21 regulates epidermal growth factor receptor in prostate cancer","volume":"7","author":"Bucay","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1756-8722-3-37","article-title":"The clinical potential of microRNAs","volume":"3","author":"Budhu","year":"2010","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib24","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1056\/NEJMra072367","article-title":"Oncogenes and cancer","volume":"358","author":"Croce","year":"2008","journal-title":"New Engl. J. Med."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jconrel.2014.06.042","article-title":"Progress of drug-loaded polymeric micelles into clinical studies","volume":"190","author":"Cabral","year":"2014","journal-title":"J. Controlled Release"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib26","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/nano6070131","article-title":"Lipid nanovectors to deliver RNA oligonucleotides in cancer","volume":"6","author":"Campani","year":"2016","journal-title":"Nanomaterials"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib28","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.3892\/or.2016.4643","article-title":"miR-1284 modulates multidrug resistance of gastric cancer cells by targeting EIF4A1","volume":"35","author":"Cao","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1358\/dof.2010.035.03.1470166","article-title":"Oncolytic herpes simplex virus 1 (HSV-1) vectors: increasing treatment efficacy and range through strategic virus design","volume":"35","author":"Carson","year":"2010","journal-title":"Drugs Future"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib30","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cell.2009.01.035","article-title":"Origins and mechanisms of miRNAs and siRNAs","volume":"136","author":"Carthew","year":"2009","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib31","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1016\/j.actbio.2011.06.018","article-title":"Size-dependent transfection efficiency of PEI-coated gold nanoparticles","volume":"7","author":"Cebri\u00e1n","year":"2011","journal-title":"Acta Biomater."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib32","series-title":"Gene Delivery Systems: Recent Progress in Viral and Non-viral Therapy","author":"Cevher","year":"2012"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib33","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.addr.2009.07.013","article-title":"Electrohydrodynamics: a facile technique to fabricate drug delivery systems","volume":"61","author":"Chakraborty","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib34","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.molcel.2007.05.010","article-title":"Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis","volume":"26","author":"Chang","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-1-60761-416-6_11","article-title":"Molecular mechanism of ATP-dependent solute transport by multidrug resistance-associated protein 1","volume":"596","author":"Chang","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib36","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.addr.2007.04.010","article-title":"Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system","volume":"59","author":"Chattopadhyay","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib37","doi-asserted-by":"crossref","first-page":"7971","DOI":"10.1166\/jnn.2015.11233","article-title":"Simultaneous drug and gene delivery from the biodegradable poly(epsilon-caprolactone) nanofibers for the treatment of liver cancer","volume":"15","author":"Che","year":"2015","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib38","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.2147\/IJN.S111950","article-title":"Decoration of pH-sensitive copolymer micelles with tumor-specific peptide for enhanced cellular uptake of doxorubicin","volume":"11","author":"Chen","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib39","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1039\/C6BM00070C","article-title":"Electrospun nanofibers for cancer diagnosis and therapy","volume":"4","author":"Chen","year":"2016","journal-title":"Biomater. Sci."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib40","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1039\/c0cs00097c","article-title":"Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives","volume":"40","author":"Cheng","year":"2011","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib41","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1021\/bm2006455","article-title":"Synthesis of biocompatible PEG-Based star polymers with cationic and degradable core for siRNA delivery","volume":"12","author":"Cho","year":"2011","journal-title":"Biomacromolecules"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4161\/rna.8.1.14259","article-title":"MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1","volume":"8","author":"Cho","year":"2011","journal-title":"RNA Biol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib43","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/01480540903493507","article-title":"Comparative studies on the genotoxicity and cytotoxicity of polymeric gene carriers polyethylenimine (PEI) and polyamidoamine (PAMAM) dendrimer in jurkat T-cells","volume":"33","author":"Choi","year":"2010","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib44","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s12033-007-0010-8","article-title":"Gene delivery by lentivirus vectors","volume":"36","author":"Cockrell","year":"2007","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib45","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tcb.2008.11.003","article-title":"Shedding microvesicles: artefacts no more","volume":"19","author":"Cocucci","year":"2009","journal-title":"Trends Cell. Biol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib46","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nrg2634","article-title":"Causes and consequences of microRNA dysregulation in cancer","volume":"10","author":"Croce","year":"2009","journal-title":"Nat. Rev. Genet"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib47","series-title":"Antisense Drug Technology: Principles, Strategies, and Applications","author":"Crooke","year":"2007"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib48","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/cncr.27903","article-title":"Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer","volume":"119","author":"Cui","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib49","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/CMR.00008-08","article-title":"Gene therapy using adeno-associated virus vectors","volume":"21","author":"Daya","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"issue":"31","key":"10.1016\/B978-0-12-813689-8.00014-8_bib146","doi-asserted-by":"crossref","first-page":"49217","DOI":"10.18632\/oncotarget.10247","article-title":"MiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppression","volume":"7","author":"de Melo Maia","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib178","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijpharm.2007.03.015","article-title":"Solid lipid nanoparticles: formulation factors affecting cell transfection capacity","volume":"339","author":"del Pozo-Rodriguez","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib179","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejpb.2016.10.016","article-title":"Applications of lipid nanoparticles in gene therapy","volume":"109","author":"del Pozo-Rodriguez","year":"2016","journal-title":"Eur. J. Pharm. Biopharm"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib50","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.nantod.2012.08.005","article-title":"Biodegradable polymeric micelles for targeted and controlled anticancer drug delivery: promises, progress and prospects","volume":"7","author":"Deng","year":"2012","journal-title":"Nano Today"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2006.08.013","article-title":"Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach","volume":"116","author":"Des rieux","year":"2006","journal-title":"J. Controlled Release"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib52","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1021\/nn507465d","article-title":"Polymer nanoparticles mediated codelivery of antimiR-10b and antimiR-21 for achieving triple negative breast cancer therapy","volume":"9","author":"Devulapally","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib139","doi-asserted-by":"crossref","first-page":"e90005","DOI":"10.1371\/journal.pone.0090005","article-title":"In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma","volume":"9","author":"Di Martino","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib53","doi-asserted-by":"crossref","first-page":"11015","DOI":"10.1021\/acsami.5b02803","article-title":"Multifunctional poly(l-lactide)-polyethylene glycol-grafted graphene quantum dots for intracellular microRNA imaging and combined specific-gene-targeting agents delivery for improved therapeutics","volume":"7","author":"Dong","year":"2015","journal-title":"ACS Appl. Mater. Interf."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib54","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.nano.2009.05.005","article-title":"Dendrimer nanocarriers as versatile vectors in gene delivery","volume":"6","author":"Dutta","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib55","series-title":"Smart Bioconjugates. Smart Biomaterials","author":"Ebara","year":"2014"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib56","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00005-010-0063-4","article-title":"Lentiviral vectors in gene therapy: their current status and future potential","volume":"58","author":"Escors","year":"2010","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib57","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/ics.12109","article-title":"Characterization, sensorial evaluation and moisturizing efficacy of nanolipidgel formulations","volume":"36","author":"Estanqueiro","year":"2014","journal-title":"Int. J. Cosmet. Sci."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib58","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.colsurfb.2014.12.041","article-title":"Nanotechnological carriers for cancer chemotherapy: the state of the art","volume":"126","author":"Estanqueiro","year":"2015","journal-title":"Colloids Surf. B"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib59","doi-asserted-by":"crossref","first-page":"15805","DOI":"10.1073\/pnas.0707628104","article-title":"MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B","volume":"104","author":"Fabbri","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib60","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13046-015-0216-8","article-title":"Dual loading miR-218 mimics and temozolomide using AuCOOH@FA-CS drug delivery system: promising targeted anti-tumor drug delivery system with sequential release functions","volume":"34","author":"Fan","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib61","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4161\/cbt.11.1.13965","article-title":"Deregulated expression of sprouty2 and microRNA-21 in human colon cancer: correlation with the clinical stage of the disease","volume":"11","author":"Feng","year":"2011","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib62","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib63","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.drup.2007.02.002","article-title":"Multiple paths to a drug resistance phenotype: mutations, translocations, deletions and amplification of coding genes or promoter regions, epigenetic changes and microRNAs","volume":"10","author":"Fojo","year":"2007","journal-title":"Drug Resist. Updat"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib64","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/14728222.2016.1181753","article-title":"An oncogenic role of miR-592 in tumorigenesis of human colorectal cancer by targeting Forkhead Box O3A (FoxO3A)","volume":"20","author":"Fu","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib65","doi-asserted-by":"crossref","first-page":"5254","DOI":"10.3390\/ijms16035254","article-title":"Development of small RNA delivery systems for lung cancer therapy","volume":"16","author":"Fujita","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib66","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1016\/j.biomaterials.2013.01.077","article-title":"Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors","volume":"34","author":"Ganesh","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib67","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/marc.201200005","article-title":"Development of star polymers as unimolecular containers for nanomaterials","volume":"33","author":"Gao","year":"2012","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib68","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/nbt994","article-title":"In vivo cancer targeting and imaging with semiconductor quantum dots","volume":"22","author":"Gao","year":"2004","journal-title":"Nat. Biotech."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib69","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.copbio.2004.11.003","article-title":"In vivo molecular and cellular imaging with quantum dots","volume":"16","author":"Gao","year":"2005","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib70","first-page":"187","article-title":"Therapeutic siRNA: principles, challenges, and strategies","volume":"85","author":"Gavrilov","year":"2012","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib71","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1385\/ABAB:133:1:9","article-title":"Adenoviral vectors","volume":"133","author":"Ghosh","year":"2006","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib72","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1359-6446(04)03276-3","article-title":"Dendrimers and dendritic polymers in drug delivery","volume":"10","author":"Gillies","year":"2005","journal-title":"Drug Discov. Today"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib73","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-1-4939-0428-0_5","article-title":"Engineering HSV-1 vectors for gene therapy","volume":"1144","author":"Goins","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib74","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.actbio.2016.02.013","article-title":"Cationic, amphiphilic copolymer micelles as nucleic acid carriers for enhanced transfection in rat spinal cord","volume":"35","author":"Gwak","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib75","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/cgt.2013.82","article-title":"Critical role of miR-10b in transforming growth factor-beta1-induced epithelial-mesenchymal transition in breast cancer","volume":"21","author":"Han","year":"2014","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib76","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/10837450.2014.996900","article-title":"Nanostructured lipid carriers as novel drug delivery system for lung cancer gene therapy","volume":"21","author":"Han","year":"2016","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib77","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.bbrc.2011.02.086","article-title":"MicroRNA 421 suppresses DPC4\/Smad4 in pancreatic cancer","volume":"406","author":"Hao","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib78","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/10409238.2015.1117054","article-title":"Dysregulation of microRNA biogenesis machinery in cancer","volume":"51","author":"Hata","year":"2016","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib79","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/nature05939","article-title":"A microRNA component of the p53 tumour suppressor network","volume":"447","author":"He","year":"2007","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib80","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.biopha.2016.01.026","article-title":"The role of oncomirs in the pathogenesis and treatment of breast cancer","volume":"78","author":"Hemmatzadeh","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib81","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/cdd.2009.56","article-title":"The miR-34 family in cancer and apoptosis","volume":"17","author":"Hermeking","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib82","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jconrel.2005.06.014","article-title":"Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids","volume":"107","author":"Heyes","year":"2005","journal-title":"J. Controlled Release"},{"issue":"14","key":"10.1016\/B978-0-12-813689-8.00014-8_bib83","doi-asserted-by":"crossref","first-page":"22443","DOI":"10.18632\/oncotarget.12338","article-title":"MicroRNA-382-5p aggravates breast cancer progression by regulating the RERG\/Ras\/ERK signaling axis","volume":"8","author":"Ho","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib84","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jconrel.2014.04.018","article-title":"Electrospinning of polymeric nanofibers for drug delivery applications","volume":"185","author":"Hu","year":"2014","journal-title":"J. Controlled Release"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib85","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jconrel.2011.06.004","article-title":"Inorganic nanoparticles for cancer imaging and therapy","volume":"155","author":"Huang","year":"2011","journal-title":"J. Controlled Release"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib86","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.biotechadv.2012.10.001","article-title":"Development of hybrid viral vectors for gene therapy","volume":"31","author":"Huang","year":"2013","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib87","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1016\/j.biomaterials.2007.07.014","article-title":"Biological applications of quantum dots","volume":"28","author":"Jamieson","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib88","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/hed.21699","article-title":"Frequency of cells expressing CD44, a head and neck cancer stem cell marker: correlation with tumor aggressiveness","volume":"34","author":"Joshua","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib89","first-page":"23","article-title":"Cytotoxic impacts of linear and branched polyethylenimine nanostructures in A431 cells","volume":"1","author":"Kafil","year":"2011","journal-title":"Bioimpacts"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2014.04.018","article-title":"Curcumin-primed exosomes mitigate endothelial cell dysfunction during hyperhomocysteinemia","volume":"107","author":"Kalani","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib91","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/ijms17020170","article-title":"Focus on extracellular vesicles: introducing the next small big thing","volume":"17","author":"Kalra","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib92","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.bbamem.2012.03.013","article-title":"Physicochemical characterization of anionic lipid-based ternary siRNA complexes","volume":"1818","author":"Kapoor","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib93","doi-asserted-by":"crossref","first-page":"e659","DOI":"10.1038\/cddis.2013.193","article-title":"miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer","volume":"4","author":"Karaayvaz","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib94","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0169-409X(00)00124-1","article-title":"Block copolymer micelles for drug delivery: design, characterization and biological significance","volume":"47","author":"Kataoka","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib95","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-3-319-42059-2_6","article-title":"MicroRNA methylation in colorectal cancer","volume":"937","author":"Kaur","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib96","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1023\/A:1016248701505","article-title":"The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake","volume":"12","author":"Kawabata","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib97","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.progpolymsci.2013.07.005","article-title":"Dendrimer as nanocarrier for drug delivery","volume":"39","author":"Kesharwani","year":"2014","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib98","doi-asserted-by":"crossref","first-page":"H217","DOI":"10.1002\/adma.201102313","article-title":"Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers","volume":"23","author":"Kievit","year":"2011","journal-title":"Adv. Mater."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib99","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.biomaterials.2011.11.020","article-title":"Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials","volume":"33","author":"Kim","year":"2012","journal-title":"Biomaterials"},{"issue":"21","key":"10.1016\/B978-0-12-813689-8.00014-8_bib100","doi-asserted-by":"crossref","first-page":"6424","DOI":"10.1158\/0008-5472.CAN-16-1571","article-title":"Ablation of miR-10b suppresses oncogene-induced mammary tumorigenesis and metastasis and reactivates tumor-suppressive pathways","volume":"76","author":"Kim","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib101","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1083\/jcb.201103097","article-title":"A p53\/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition","volume":"195","author":"Kim","year":"2011","journal-title":"J. Cell Biol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib102","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1517\/17425240903380446","article-title":"Overcoming the barriers in micellar drug delivery: loading efficiency, in vivo stability, and micelle-cell interaction","volume":"7","author":"Kim","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib103","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/pros.21185","article-title":"MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms","volume":"70","author":"Kojima","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib104","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.pharmtox.43.100901.140257","article-title":"Gene therapy with viral vectors","volume":"43","author":"Kootstra","year":"2003","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib105","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.cell.2009.04.021","article-title":"Therapeutic delivery of miR-26a inhibits cancer cell proliferation and induces tumor-specific apoptosis","volume":"137","author":"Kota","year":"2009","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib106","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.progpolymsci.2013.10.004","article-title":"Loading of polymer nanocarriers: factors, mechanisms and applications","volume":"39","author":"Kowalczuk","year":"2014","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib107","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jbm.820050305","article-title":"Biodegradable poly(lactic acid) polymers","volume":"5","author":"Kulkarni","year":"1971","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfb.2009.09.001","article-title":"Biodegradable polymeric nanoparticles based drug delivery systems","volume":"75","author":"Kumari","year":"2010","journal-title":"Colloids Surf. B"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib109","doi-asserted-by":"crossref","first-page":"584549","DOI":"10.1155\/2013\/584549","article-title":"Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability","volume":"2013","author":"Kushwaha","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib110","doi-asserted-by":"crossref","first-page":"a000893","DOI":"10.1101\/cshperspect.a000893","article-title":"p53 Research: the past thirty years and the next thirty years","volume":"2","author":"Lane","year":"2010","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib111","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11897-011-0068-2","article-title":"Therapeutic use of microRNAs in myocardial diseases","volume":"8","author":"Latronico","year":"2011","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib112","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1158\/1078-0432.CCR-09-0051","article-title":"MicroRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cells","volume":"15","author":"Lee","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib113","first-page":"1118","article-title":"Nanoparticle-based targeted gene therapy for lung cancer","volume":"6","author":"Lee","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib114","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib115","doi-asserted-by":"crossref","first-page":"8481","DOI":"10.1074\/jbc.271.14.8481","article-title":"Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer","volume":"271","author":"Lee","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib116","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/gt.2011.100","article-title":"Chemical modification and design of anti-miRNA oligonucleotides","volume":"18","author":"Lennox","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib117","first-page":"112","article-title":"Vector-mediated gene therapy and the herpes simplex virus","volume":"2","author":"Levesque","year":"2004","journal-title":"BioTeach J."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib118","doi-asserted-by":"crossref","first-page":"19729","DOI":"10.3390\/ijms151119729","article-title":"Overexpression of microRNA-30b improves adenovirus-mediated p53 cancer gene therapy for laryngeal carcinoma","volume":"15","author":"Li","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib119","first-page":"2004","article-title":"MiR-181a upregulation is associated with epithelial-to-mesenchymal transition (EMT) and multidrug resistance (MDR) of ovarian cancer cells","volume":"20","author":"Li","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib120","doi-asserted-by":"crossref","first-page":"10011","DOI":"10.1007\/s13277-014-1921-1","article-title":"Downregulation of tumor suppressor menin by miR-421 promotes proliferation and migration of neuroblastoma","volume":"35","author":"Li","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib121","doi-asserted-by":"crossref","first-page":"23772","DOI":"10.1038\/srep23772","article-title":"miR-93 functions as an oncomiR for the downregulation of PDCD4 in gastric carcinoma","volume":"6","author":"Liang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib122","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.4161\/cc.20207","article-title":"The emerging functions of the p53-miRNA network in stem cell biology","volume":"11","author":"Lin","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib123","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nm.2284","article-title":"The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44","volume":"17","author":"Liu","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib124","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bbrc.2016.10.004","article-title":"miR-144-3p serves as a tumor suppressor for renal cell carcinoma and inhibits its invasion and metastasis by targeting MAP3K8","volume":"480","author":"Liu","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib125","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1039\/C2TB00121G","article-title":"Inhibition of orthotopic secondary hepatic carcinoma in mice by doxorubicin-loaded electrospun polylactide nanofibers","volume":"1","author":"Liu","year":"2013","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib126","first-page":"3223","article-title":"MiR-375 is epigenetically downregulated due to promoter methylation and modulates multi-drug resistance in breast cancer cells via targeting YBX1","volume":"20","author":"Liu","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib127","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s13238-016-0313-2","article-title":"miR-181b functions as an oncomiR in colorectal cancer by targeting PDCD4","volume":"7","author":"Liu","year":"2016","journal-title":"Protein Cell"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib128","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1039\/C5BM00277J","article-title":"Utilising inorganic nanocarriers for gene delivery","volume":"4","author":"Loh","year":"2016","journal-title":"Biomater. Sci."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib129","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1039\/b926893f","article-title":"Using graphene to protect DNA from cleavage during cellular delivery","volume":"46","author":"Lu","year":"2010","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib130","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.biopha.2016.09.047","article-title":"Enhanced miR-9 promotes laryngocarcinoma cell survival via down-regulating PTEN","volume":"84","author":"Lu","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib131","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1586\/erm.09.15","article-title":"Current advances in research and clinical applications of PLGA-based nanotechnology","volume":"9","author":"Lu","year":"2009","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib132","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1134\/S0006297916070063","article-title":"Viral vectors for gene therapy: current state and clinical perspectives","volume":"81","author":"Lukashev","year":"2016","journal-title":"Biochemistry (Moscow)"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib133","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0167-7799(02)00042-2","article-title":"Latest development in viral vectors for gene therapy","volume":"21","author":"Lundstrom","year":"2003","journal-title":"Trends Biotechnol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib134","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2006.04.014","article-title":"Toxicity of cationic lipids and cationic polymers in gene delivery","volume":"114","author":"Lv","year":"2006","journal-title":"J. Controlled Release"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib135","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.tig.2008.06.004","article-title":"Micromanagers of malignancy: role of microRNAs in regulating metastasis","volume":"24","author":"Ma","year":"2008","journal-title":"Trends Genet."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib136","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1166\/jnn.2014.9080","article-title":"Liposomes: versatile and biocompatible nanovesicles for efficient biomolecules delivery","volume":"14","author":"Mallick","year":"2014","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib137","first-page":"123","article-title":"HSV recombinant vectors for gene therapy","volume":"4","author":"Manservigi","year":"2010","journal-title":"Open Virol. J."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib138","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1200\/JCO.2008.17.5554","article-title":"Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a cancer and leukemia group B study","volume":"26","author":"Marcucci","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib140","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.msec.2015.11.067","article-title":"Polymeric nanoparticles for targeted drug delivery system for cancer therapy","volume":"60","author":"Masood","year":"2016","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"44","key":"10.1016\/B978-0-12-813689-8.00014-8_bib141","doi-asserted-by":"crossref","first-page":"72084","DOI":"10.18632\/oncotarget.12290","article-title":"Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma","volume":"7","author":"Mataki","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib142","first-page":"349","article-title":"Retroviral vectors and gene therapy: an update","volume":"8","author":"Maurya","year":"2009","journal-title":"Indian J. Biotechnol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib143","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/mt.2014.177","article-title":"Use of miRNA response sequences to block off-target replication and increase the safety of an unattenuated, glioblastoma-targeted oncolytic HSV","volume":"23","author":"Mazzacurati","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib144","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1044-579X(03)00038-5","article-title":"MicroRNAs and cancer","volume":"13","author":"McManus","year":"2003","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib145","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.molcel.2004.07.007","article-title":"Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs","volume":"15","author":"Meister","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib147","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","article-title":"MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer","volume":"133","author":"Meng","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib148","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fphar.2016.00329","article-title":"MicroRNA-based therapy in animal models of selected gastrointestinal cancers","volume":"7","author":"Merhautova","year":"2016","journal-title":"Front Pharmacol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib149","first-page":"882","article-title":"Reduced accumulation of specific microRNAs in colorectal neoplasia","volume":"1","author":"Michael","year":"2003","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib150","first-page":"127","article-title":"Human gene therapy: a brief overview of the genetic revolution","volume":"61","author":"Misra","year":"2013","journal-title":"J. Assoc. Phys. India"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib151","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.1016\/j.biomaterials.2014.04.053","article-title":"Efficacy of gemcitabine conjugated and miRNA-205 complexed micelles for treatment of advanced pancreatic cancer","volume":"35","author":"Mittal","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib152","unstructured":"MirnaTherapeutics. 2016. MicroRNA Therapeutics [Online]. <http:\/\/www.mirnatherapeutics.com\/about\/mirna-aboutus.html> (accessed 13.11.16, 2017.)."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib153","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s40139-013-0008-9","article-title":"MicroRNA and epigenetics: diagnostic and therapeutic opportunities","volume":"1","author":"Monroig","year":"2013","journal-title":"Curr. Pathobiol. Rep."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib154","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1517\/17425247.2013.798640","article-title":"Nanoparticle-mediated delivery of therapeutic genes: focus on miRNA therapeutics","volume":"10","author":"Muthiah","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib155","doi-asserted-by":"crossref","first-page":"305","DOI":"10.15171\/apb.2015.043","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers: structure, preparation and application","volume":"5","author":"Naseri","year":"2015","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib156","first-page":"A1123","article-title":"Targeted siRNA delivery using a novel anionic lipid\/polyhedral oligomeric silsesquioxane complex system for malignant pleural mesothelioma","volume":"191","author":"Nasreen","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib157","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1021\/mp5007213","article-title":"Micelle-like nanoparticles as carriers for DNA and siRNA","volume":"12","author":"Navarro","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib158","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.cellsig.2013.03.013","article-title":"Activin and TGFbeta regulate expression of the microRNA-181 family to promote cell migration and invasion in breast cancer cells","volume":"25","author":"Neel","year":"2013","journal-title":"Cell Signal"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib159","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2174\/157488706775246148","article-title":"Combined modality treatment of glioblastoma multiforme: the role of temozolomide","volume":"1","author":"Nieder","year":"2006","journal-title":"Rev. Recent Clin. Trials"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib160","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3390\/ijms17020172","article-title":"Focus on extracellular vesicles: development of extracellular vesicle-based therapeutic systems","volume":"17","author":"Ohno","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib161","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1101\/gad.233585.113","article-title":"A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression","volume":"28","author":"Okada","year":"2014","journal-title":"Genes Dev."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib162","doi-asserted-by":"crossref","first-page":"7842","DOI":"10.1021\/ma000877i","article-title":"Formation of supramolecular structures between DNA and starburst dendrimers studied by EPR, CD, UV, and melting profiles","volume":"33","author":"Ottaviani","year":"2000","journal-title":"Macromolecules"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib163","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.addr.2013.12.008","article-title":"Liposomal siRNA nanocarriers for cancer therapy","volume":"66","author":"Ozpolat","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib164","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrd1775","article-title":"Design and development of polymers for gene delivery","volume":"4","author":"Pack","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib165","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/jcp.24486","article-title":"Microvesicle-shuttled miR-130b reduces fat deposition in recipient primary cultured porcine adipocytes by inhibiting PPAR-g expression","volume":"229","author":"Pan","year":"2014","journal-title":"J. Cell Physiol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib166","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.biopha.2016.08.058","article-title":"MicroRNA-421 inhibits breast cancer metastasis by targeting metastasis associated 1","volume":"83","author":"Pan","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib167","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0169-409X(02)00228-4","article-title":"Biodegradable nanoparticles for drug and gene delivery to cells and tissue","volume":"55","author":"Panyam","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib168","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jconrel.2014.07.042","article-title":"Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery","volume":"192","author":"Pascucci","year":"2014","journal-title":"J. Controlled Release"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib169","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1208\/aapsj060429","article-title":"Anionic liposomal delivery system for DNA transfection","volume":"6","author":"Patil","year":"2004","journal-title":"AAPS J."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib170","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1517\/17425247.2013.744964","article-title":"Novel polyethylenimine-derived nanoparticles for in vivo gene delivery","volume":"10","author":"Patnaik","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib171","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12885-016-2231-3","article-title":"Relevance of miR-21 in regulation of tumor suppressor gene PTEN in human cervical cancer cells","volume":"16","author":"Peralta-Zaragoza","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib172","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1089\/ten.2006.12.1197","article-title":"Electrospinning of polymeric nanofibers for tissue engineering applications: a review","volume":"12","author":"Pham","year":"2006","journal-title":"Tissue Eng."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib173","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.biomaterials.2006.07.032","article-title":"Virus-based gene therapy strategies for bone regeneration","volume":"28","author":"Phillips","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib174","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/jclinpath-2013-201904","article-title":"miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor","volume":"67","author":"Pichler","year":"2014","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib175","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.2174\/1568026616666160715163346","article-title":"Gold and silver nanoparticles for applications in theranostics","volume":"16","author":"Pietro","year":"2016","journal-title":"Curr. Top Med. Chem."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib176","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1007\/s00204-016-1815-7","article-title":"MicroRNA epigenetic signatures in human disease","volume":"90","author":"Piletic","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib177","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1155\/2013\/789289","article-title":"A review of the effect of processing variables on the fabrication of electrospun nanofibers for drug delivery applications","volume":"2013","author":"Pillay","year":"2013","journal-title":"J. Nanomater."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib180","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.gendis.2014.06.004","article-title":"MicroRNAs in cancer biology and therapy: current status and perspectives","volume":"1","author":"Price","year":"2014","journal-title":"Genes Dis."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib181","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.biomaterials.2013.11.039","article-title":"Star-branched amphiphilic PLA-b-PDMAEMA copolymers for co-delivery of miR-21 inhibitor and doxorubicin to treat glioma","volume":"35","author":"Qian","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib182","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.progpolymsci.2011.01.001","article-title":"Polymer nanoparticles: preparation techniques and size-control parameters","volume":"36","author":"Rao","year":"2011","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib183","first-page":"1454","article-title":"The effect and mechanism of microRNA-21 on cis-dichlorodiamineplatinum resistance in lung cancer cell strain","volume":"96","author":"Ren","year":"2016","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib184","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1016\/j.biomaterials.2007.08.047","article-title":"Hydrolysable core-crosslinked thermosensitive polymeric micelles: synthesis, characterisation and in vivo studies","volume":"28","author":"Rijcken","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib185","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.addr.2007.04.020","article-title":"Formation of fibers by electrospinning","volume":"59","author":"Rutledge","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib186","first-page":"1263","article-title":"The involvement of microRNAs in malignant transformation","volume":"27","author":"Rutnam","year":"2012","journal-title":"Histol. Histopathol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib187","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1016\/j.biomaterials.2011.12.045","article-title":"Gene delivery using dendrimer-entrapped gold nanoparticles as nonviral vectors","volume":"33","author":"Shan","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib188","doi-asserted-by":"crossref","first-page":"e0159601","DOI":"10.1371\/journal.pone.0159601","article-title":"miR-9 Acts as an oncomiR in prostate cancer through multiple pathways that drive tumour progression and metastasis","volume":"11","author":"Seashols-Williams","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib189","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2174\/13894501113149990185","article-title":"Targeting miR-21 induces autophagy and chemosensitivity of leukemia cells","volume":"14","author":"Seca","year":"2013","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib190","series-title":"MicroRNAs: Key Regulators of Oncogenesis","article-title":"MicroRNAs in cancer drug resistance and drug sensitivity","author":"Seca","year":"2014"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib191","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.clinre.2016.02.010","article-title":"Significance of microRNA 21 in gastric cancer","volume":"40","author":"Sekar","year":"2016","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib192","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0005-2736(00)00343-6","article-title":"Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures","volume":"1510","author":"Semple","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib193","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nbt.1602","article-title":"Rational design of cationic lipids for siRNA delivery","volume":"28","author":"Semple","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib194","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jconrel.2014.09.005","article-title":"Dual drugs (microRNA-34a and paclitaxel)-loaded functional solid lipid nanoparticles for synergistic cancer cell suppression","volume":"194","author":"Shi","year":"2014","journal-title":"J. Controlled Release"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib195","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.biomaterials.2008.01.011","article-title":"Electrospinning: applications in drug delivery and tissue engineering","volume":"29","author":"Sill","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib196","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3390\/s120100612","article-title":"Aptamers and their biological applications","volume":"12","author":"Song","year":"2012","journal-title":"Sensors (Basel)"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib197","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-907X-3-1","article-title":"Inhibition of microRNA function by antimiR oligonucleotides","volume":"3","author":"Stenvang","year":"2012","journal-title":"Silence"},{"issue":"47","key":"10.1016\/B978-0-12-813689-8.00014-8_bib198","doi-asserted-by":"crossref","first-page":"77430","DOI":"10.18632\/oncotarget.12679","article-title":"c-Myc suppresses miR-451 dash, verticalYWTAZ\/AKT axis via recruiting HDAC3 in acute myeloid leukemia","volume":"7","author":"Su","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib199","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.2147\/IJN.S33666","article-title":"PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells","volume":"7","author":"Su","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib200","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1021\/bm200604h","article-title":"Folic acid conjugated amino acid-based star polymers for active targeting of cancer cells","volume":"12","author":"Sulistio","year":"2011","journal-title":"Biomacromolecules"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib201","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s12250-012-3266-5","article-title":"The miRNAs of herpes simplex virus (HSV)","volume":"27","author":"Sun","year":"2012","journal-title":"Virol. Sin."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib202","doi-asserted-by":"crossref","first-page":"14343","DOI":"10.1039\/C4NR03003F","article-title":"In vivo multimodality imaging of miRNA-16 iron nanoparticle reversing drug resistance to chemotherapy in a mouse gastric cancer model","volume":"6","author":"Sun","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib203","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejpb.2008.09.023","article-title":"Dendrimers as versatile platform in drug delivery applications","volume":"71","author":"Svenson","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib204","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1101\/gr.201517.115","article-title":"Three-dimensional disorganization of the cancer genome occurs coincident with long-range genetic and epigenetic alterations","volume":"26","author":"Taberlay","year":"2016","journal-title":"Genome Res."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib205","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.tibtech.2011.06.009","article-title":"Molecular aptamers for drug delivery","volume":"29","author":"Tan","year":"2011","journal-title":"Trends Biotechnol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib206","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2013.04.020","article-title":"Oral delivery of anticancer drugs: challenges and opportunities","volume":"170","author":"Thanki","year":"2013","journal-title":"J. Controlled Release"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib207","doi-asserted-by":"crossref","first-page":"7309","DOI":"10.4049\/jimmunol.166.12.7309","article-title":"Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles","volume":"166","author":"Th\u00e9ry","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib208","doi-asserted-by":"crossref","DOI":"10.1002\/0471143030.cb0322s30","article-title":"Isolation and characterization of exosomes from cell culture supernatants and biological fluids","author":"Th\u00e9ry","year":"2006","journal-title":"Curr. Protoc. Cell Biol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib209","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri2567","article-title":"Membrane vesicles as conveyors of immune responses","volume":"9","author":"Th\u00e9ry","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib210","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrg1066","article-title":"Progress and problems with the use of viral vectors for gene therapy","volume":"4","author":"Thomas","year":"2003","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib211","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrg1066","article-title":"Progress and problems with the use of viral vectors for gene therapy","volume":"4","author":"Thomas","year":"2003","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib212","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.biomaterials.2013.11.083","article-title":"A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy","volume":"35","author":"Tian","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib213","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.addr.2015.10.002","article-title":"A novel platform for cancer therapy using extracellular vesicles","volume":"95","author":"Tominaga","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib214","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1038\/onc.2009.353","article-title":"MicroRNAs as potential cancer therapeutics","volume":"27","author":"Trang","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib215","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.1158\/0008-5472.CAN-13-0358","article-title":"MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1","volume":"73","author":"Tu","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib216","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1517\/17425247.3.5.629","article-title":"Pharmaceutical nanotechnology: polymeric vesicles for drug and gene delivery","volume":"3","author":"Uchegbu","year":"2006","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib217","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijpharm.2016.10.013","article-title":"Nanomedicines for advanced cancer treatments: transitioning towards responsive systems","volume":"515","author":"van Elk","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib218","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0031-6865(95)00010-7","article-title":"Preparation and characterization of liposomes as therapeutic delivery systems: a review","volume":"70","author":"Vemuri","year":"1995","journal-title":"Pharm. Acta Helv."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib219","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/1521-2254(200009\/10)2:5<308::AID-JGM131>3.0.CO;2-3","article-title":"Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy","volume":"2","author":"Vigna","year":"2000","journal-title":"J. Gene Med."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib220","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib221","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.bbamcr.2010.06.013","article-title":"MicroRNAs: synthesis, mechanism, function, and recent clinical trials","volume":"1803","author":"Wahid","year":"2010","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib222","series-title":"Pharmaceutical Biotechnology: Concepts and Applications","author":"Walsh","year":"2007"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib223","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2165\/00003495-200060020-00002","article-title":"Viral vectors for gene transfer a review of their use in the treatment of human disease","volume":"60","author":"Walter","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib224","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1038\/onc.2009.468","article-title":"TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3","volume":"29","author":"Wang","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib226","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.3892\/ol.2015.3663","article-title":"MicroRNA-181a enhances the chemotherapeutic sensitivity of chronic myeloid leukemia to imatinib","volume":"10","author":"Wang","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib227","doi-asserted-by":"crossref","first-page":"e0139136","DOI":"10.1371\/journal.pone.0139136","article-title":"Aptamer-dendrimer bioconjugates for targeted delivery of miR-34a expressing plasmid and antitumor effects in non-small cell lung cancer cells","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib228","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ddr.21275","article-title":"The role of microRNAs in the chemoresistance of breast cancer","volume":"76","author":"Wang","year":"2015","journal-title":"Drug Dev. Res."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib225","doi-asserted-by":"crossref","first-page":"9014","DOI":"10.1021\/acsami.6b02662","article-title":"Imaging dendrimer-grafted graphene oxide mediated anti-miR-21 delivery with an activatable luciferase reporter","volume":"8","author":"Wang","year":"2016","journal-title":"ACS Appl. Mater. Interf."},{"issue":"1","key":"10.1016\/B978-0-12-813689-8.00014-8_bib229","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/09168451.2016.1238294","article-title":"miR-30 functions as an oncomiR in gastric cancer cells through regulation of P53-mediated mitochondrial apoptotic pathway","volume":"81","author":"Wang","year":"2016","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib230","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.biopha.2016.09.108","article-title":"miR-10b promotes invasion by targeting KLF4 in osteosarcoma cells","volume":"84","author":"Wang","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib231","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.7314\/APJCP.2015.16.10.4203","article-title":"Macrophage-secreted exosomes delivering miRNA-21 inhibitor can regulate BGC-823 cell proliferation","volume":"16","author":"Wang","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib232","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.18632\/oncotarget.3465","article-title":"MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib233","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.nano.2015.09.014","article-title":"Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy","volume":"12","author":"Wang","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib234","doi-asserted-by":"crossref","first-page":"9733","DOI":"10.1007\/s13277-015-3743-1","article-title":"The effect of recombinant lentiviral vector encoding miR-145 on human esophageal cancer cells","volume":"36","author":"Wang","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib235","first-page":"46","article-title":"Non-viral gene delivery methods","volume":"14","author":"Wang","year":"2013","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib236","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2016.08.004","article-title":"Engineering biodegradable micelles of polyethylenimine-based amphiphilic block copolymers for efficient DNA and siRNA delivery","volume":"242","author":"Wang","year":"2016","journal-title":"J. Controlled Release"},{"issue":"11","key":"10.1016\/B978-0-12-813689-8.00014-8_bib237","doi-asserted-by":"crossref","first-page":"15211","DOI":"10.1007\/s13277-016-5417-z","article-title":"Upregulation of miR-192 inhibits cell growth and invasion and induces cell apoptosis by targeting TCF7 in human osteosarcoma","volume":"37","author":"Wang","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib238","doi-asserted-by":"crossref","first-page":"43805","DOI":"10.18632\/oncotarget.9698","article-title":"Aberrant methylation-mediated silencing of microRNAs contributes to HPV-induced anchorage independence","volume":"7","author":"Wilting","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib239","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.bbrc.2016.07.031","article-title":"miR-613 inhibits proliferation and invasion of breast cancer cell via VEGFA","volume":"478","author":"Wu","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib240","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.7314\/APJCP.2014.15.13.5463","article-title":"MiR-421 regulates apoptosis of BGC-823 gastric cancer cells by targeting caspase-3","volume":"15","author":"Wu","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib241","doi-asserted-by":"crossref","first-page":"11552","DOI":"10.18632\/oncotarget.2594","article-title":"Methylation of miR-129-5p CpG island modulates multi-drug resistance in gastric cancer by targeting ABC transporters","volume":"5","author":"Wu","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib242","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.addr.2011.05.005","article-title":"Viral delivery for gene therapy against cell movement in cancer","volume":"63","author":"Wu","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib243","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1021\/mp2002076","article-title":"MicroRNA delivery by cationic lipoplexes for lung cancer therapy","volume":"8","author":"Wu","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib244","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12032-016-0837-6","article-title":"The novel miR-9501 inhibits cell proliferation, migration and activates apoptosis in non-small cell lung cancer","volume":"33","author":"Xi","year":"2016","journal-title":"Med. Oncol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib245","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/ijc.23501","article-title":"miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells","volume":"123","author":"Xia","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib246","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nmeth.1903","article-title":"Long-term, efficient inhibition of microRNA function in mice using rAAV vectors","volume":"9","author":"Xie","year":"2012","journal-title":"Nat. Meth."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib247","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/mc.21832","article-title":"miR-1915 inhibits Bcl-2 to modulate multidrug resistance by increasing drug-sensitivity in human colorectal carcinoma cells","volume":"52","author":"Xu","year":"2013","journal-title":"Mol. Carcinog."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib248","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.2174\/1381612821666150531164540","article-title":"Lipid-based nanocarriers for RNA delivery","volume":"21","author":"Xue","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib249","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.msec.2014.04.053","article-title":"Biocompatible core\u2013shell electrospun nanofibers as potential application for chemotherapy against ovary cancer","volume":"41","author":"Yan","year":"2014","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib250","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1021\/nn202939s","article-title":"One-pot synthesis of polypeptide\u2013gold nanoconjugates for in vitro gene transfection","volume":"6","author":"Yan","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib251","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1039\/C2CS35342C","article-title":"Nano-graphene in biomedicine: theranostic applications","volume":"42","author":"Yang","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib252","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s11095-014-1593-y","article-title":"Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio","volume":"32","author":"Yang","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib253","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3727\/096504016X14550280421449","article-title":"Plasmid-based Stat3 siRNA delivered by functional graphene oxide suppresses mouse malignant melanoma cell growth","volume":"23","author":"Yin","year":"2016","journal-title":"Oncol. Res."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib254","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib255","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jconrel.2012.05.047","article-title":"3D superhydrophobic electrospun meshes as reinforcement materials for sustained local drug delivery against colorectal cancer cells","volume":"162","author":"Yohe","year":"2012","journal-title":"J. Controlled Release"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib256","doi-asserted-by":"crossref","first-page":"14","DOI":"10.7150\/thno.13515","article-title":"Triple-layered pH-responsive micelleplexes loaded with siRNA and cisplatin prodrug for NF-kappa B targeted treatment of metastatic breast cancer","volume":"6","author":"Yu","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib257","first-page":"2997","article-title":"Advances in drug delivery via electrospun and electrosprayed nanomaterials","volume":"8","author":"Zamani","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib259","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3892\/or.2012.1645","article-title":"microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN","volume":"27","author":"Zhang","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib260","first-page":"405","article-title":"[Influence of recombinant lentiviral vector encoding miR-15a\/16-1 in biological features of human nasopharyngeal carcinoma CNE-2Z cells]","volume":"48","author":"Zhang","year":"2013","journal-title":"Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib262","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/07357907.2015.1019676","article-title":"Abnormal Expression of miR-21 and miR-95 in Cancer Stem-Like Cells is Associated with Radioresistance of Lung Cancer","volume":"33","author":"Zhang","year":"2015","journal-title":"Cancer Invest"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib267","first-page":"4825","article-title":"Targeted delivery of chemically modified antimiR-221 to hepatocellular carcinoma with negatively charged liposomes","volume":"10","author":"Zhang","year":"2015","journal-title":"Int J Nanomed."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib258","first-page":"2021","article-title":"miR-489 acts as a tumor suppressor in human gastric cancer by targeting PROX1","volume":"6","author":"Zhang","year":"2016","journal-title":"Am. J. Cancer Res."},{"issue":"10","key":"10.1016\/B978-0-12-813689-8.00014-8_bib261","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.molonc.2016.09.001","article-title":"miR-634 exhibits anti-tumor activities toward hepatocellular carcinoma via Rab1A and DHX33","volume":"10","author":"Zhang","year":"2016","journal-title":"Mol. Oncol"},{"issue":"4","key":"10.1016\/B978-0-12-813689-8.00014-8_bib263","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2174\/1574892811666160822161157","article-title":"Episomal lentiviral vector-mediated miR-145 overexpression inhibits proliferation and induces apoptosis of human esophageal carcinoma cells","volume":"11","author":"Zhang","year":"2016","journal-title":"Recent Pat. Anticancer Drug Discov"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib264","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bbrc.2016.07.054","article-title":"miR-214 promotes apoptosis and sensitizes breast cancer cells to doxorubicin by targeting the RFWD2-p53 cascade","volume":"478","author":"Zhang","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib268","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1021\/acs.molpharmaceut.5b00933","article-title":"Reducible micelleplexes are stable systems for anti-miRNA delivery in cerebrospinal fluid","volume":"13","author":"Zhang","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib265","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.cca.2010.02.074","article-title":"MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC)","volume":"411","author":"Zhang","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib266","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/smll.200901680","article-title":"Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs","volume":"6","author":"Zhang","year":"2010","journal-title":"Small"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib269","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbrc.2011.09.063","article-title":"Overexpression of microRNA-29b induces apoptosis of multiple myeloma cells through down regulating Mcl-1","volume":"414","author":"Zhang","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib270","doi-asserted-by":"crossref","first-page":"6867","DOI":"10.1007\/s13277-015-3399-x","article-title":"MicroRNA-9 promotes tumorigenesis and mediates sensitivity to cisplatin in primary epithelial ovarian cancer cells","volume":"36","author":"Zhao","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib271","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.1016\/j.biomaterials.2012.05.055","article-title":"Enhancing in vivo circulation and siRNA delivery with biodegradable polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol) copolymers","volume":"33","author":"Zheng","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib272","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1021\/bc900393r","article-title":"Transfection efficiency of cationic lipids with different hydrophobic domains in gene delivery","volume":"21","author":"Zhi","year":"2010","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib273","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.gene.2011.11.028","article-title":"MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expression","volume":"493","author":"Zhong","year":"2012","journal-title":"Gene"},{"issue":"4","key":"10.1016\/B978-0-12-813689-8.00014-8_bib274","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/path.4804","article-title":"MicroRNAs miR-125b and miR-100 suppress metastasis of hepatocellular carcinoma by disrupting the formation of vessels that encapsulate tumour clusters","volume":"240","author":"Zhou","year":"2016","journal-title":"J. Pathol"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib275","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jpba.2006.06.021","article-title":"Studies on the interactions between DNA and PAMAM with fluorescent probe [Ru(phen)2 dppz]2","volume":"43","author":"Zhou","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib276","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/ijc.25260","article-title":"miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines","volume":"127","author":"Zhu","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib277","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00280-011-1752-3","article-title":"miR-200bc\/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP","volume":"69","author":"Zhu","year":"2012","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib278","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s12032-010-9797-4","article-title":"miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2","volume":"29","author":"Zhu","year":"2012","journal-title":"Med. Oncol."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib279","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2147\/IJN.S84927","article-title":"A novel type of self-assembled nanoparticles as targeted gene carriers: an application for plasmid DNA and antimicroRNA oligonucleotide delivery","volume":"11","author":"Zhu","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/B978-0-12-813689-8.00014-8_bib280","series-title":"miRNA Maturation: Methods and Protocols","article-title":"Lentiviral Overexpression of miRNAs","author":"Z\u00f6llner","year":"2014"}],"container-title":["Drug Targeting and Stimuli Sensitive Drug Delivery Systems"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128136898000148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128136898000148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T13:51:05Z","timestamp":1604325065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128136898000148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9780128136898"],"references-count":280,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-813689-8.00014-8","relation":{},"subject":[],"published":{"date-parts":[[2018]]}}}